Matches in Wikidata for { <http://www.wikidata.org/entity/Q64641576> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q64641576 description "clinical trial" @default.
- Q64641576 description "ensayu clínicu" @default.
- Q64641576 description "klinisch onderzoek" @default.
- Q64641576 description "клінічне випробування" @default.
- Q64641576 name "A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension" @default.
- Q64641576 type Item @default.
- Q64641576 label "A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension" @default.
- Q64641576 prefLabel "A Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension" @default.
- Q64641576 P1050 Q64641576-5274F80B-C903-40FB-AE8E-B611C4B34ECD @default.
- Q64641576 P1050 Q64641576-6E8E1BA7-5949-4D04-888B-65CA107045B9 @default.
- Q64641576 P1132 Q64641576-E6A7C7E9-FE54-4999-A9EF-4D2D1FB8AC86 @default.
- Q64641576 P1476 Q64641576-DDACA19E-FE11-4D39-89C1-3C00A20988A4 @default.
- Q64641576 P1813 Q64641576-78713A03-A14F-49D5-8F69-B48719515BF9 @default.
- Q64641576 P2899 Q64641576-6D40AC32-297D-42BB-91D5-1CE4C1F8A0C3 @default.
- Q64641576 P3098 Q64641576-AA922833-8B18-47AF-8F1C-D65B3299788C @default.
- Q64641576 P31 Q64641576-15FF2D64-C0BD-4FE2-830B-6C70703D7B82 @default.
- Q64641576 P4135 Q64641576-6CE399D0-30BD-4C9E-97F5-050DC5D732BB @default.
- Q64641576 P4844 Q64641576-BA1FC25A-B440-4986-A230-5B6C4D71183B @default.
- Q64641576 P580 Q64641576-C1FFD789-255B-41C6-8F05-00A10D517409 @default.
- Q64641576 P582 Q64641576-B3D7B811-12D1-48DB-8660-7B8E42572B50 @default.
- Q64641576 P6099 Q64641576-2EA31817-E143-4897-B1E4-FFF01BE2AAA9 @default.
- Q64641576 P6153 Q64641576-A50992CC-C47C-42D0-A236-6E23BDC28EAF @default.
- Q64641576 P767 Q64641576-4E3FD3CE-3A13-4906-B8A1-C0F5BECF5A87 @default.
- Q64641576 P767 Q64641576-4F6574CE-814C-4635-932F-CFCEE738E1A2 @default.
- Q64641576 P767 Q64641576-7FD942C7-58E0-4704-BCD1-9747A3DF88B6 @default.
- Q64641576 P767 Q64641576-D6D142B9-3256-418F-86FE-4ED1B9376F7D @default.
- Q64641576 P8363 Q64641576-366C337D-31CA-48FC-B0B5-30B453E0BEDA @default.
- Q64641576 P1050 Q41861 @default.
- Q64641576 P1050 Q988405 @default.
- Q64641576 P1132 "+293" @default.
- Q64641576 P1476 "A Randomized, Double-Blind, Multicenter, Phase 3 Study to Evaluate the Antihypertensive Efficacy and Safety of Fimasartan(BR-A-657∙K) 30mg Compared to Placebo in Patients With Mild to Moderate Essential Hypertension" @default.
- Q64641576 P1813 "fimasartan" @default.
- Q64641576 P2899 "+20" @default.
- Q64641576 P3098 "NCT01672476" @default.
- Q64641576 P31 Q30612 @default.
- Q64641576 P4135 "+75" @default.
- Q64641576 P4844 Q7912612 @default.
- Q64641576 P580 "2012-04-01T00:00:00Z" @default.
- Q64641576 P582 "2013-03-01T00:00:00Z" @default.
- Q64641576 P6099 Q42824827 @default.
- Q64641576 P6153 Q39988 @default.
- Q64641576 P767 Q12623975 @default.
- Q64641576 P767 Q19794560 @default.
- Q64641576 P767 Q30280617 @default.
- Q64641576 P767 Q4803501 @default.
- Q64641576 P8363 Q78089383 @default.